- Home
- A-Z Publications
- Current Artificial Intelligence
- Previous Issues
- Volume 2, Issue 1, 2024
Current Artificial Intelligence - Volume 2, Issue 1, 2024
Volume 2, Issue 1, 2024
-
-
Artificial Intelligence in Modernization of Pharmaceutical and Healthcare Industry: A Review
Authors: Moumita Das Kirtania, Dibya Sinha, Shreya Biswas, Sania Sultana and Ranjan KirtaniaArtificial intelligence (AI) falls under the purview of computer technology, which analyzes complex data and helps solve problems in different segments. Big Data, Machine Learning, and AI are currently being used by the major pharmaceutical industries to minimize time and costs and increase possibilities. Artificial intelligence is used in the pharmaceutical industry in diverse ways, such as drug discovery and development, clinical trials, disease diagnosis, and different stages in pharmaceutical manufacturing, data analysis, and supply management. Most of the cost and time are involved in drug discovery and clinical trials. Artificial intelligence can minimize human error in data processing, documentation, data integrity issues, and data selection throughout the journey. It works in descriptive, diagnostic, predictive, and prescriptive mode. Major pharmaceutical conglomerates like Pfizer, Roche, Novartis, and Johnson & Johnson have already applied Artificial Intelligence in different segments of pharmaceutical and medicinal science. Tech companies like IBM Watson, Catalia Health, Intel, Microsoft, and Google, in collaboration with pharmaceutical companies, are working in the different areas of drug discovery, early diagnosis, and personalized medicine. Further, AI finds application in the health sector for data management, scanning and evaluation of medical history reports, and finding optimum treatment strategies for chronic care patients. Though lots of research and development are being done on the utilization of artificial intelligence in the pharmaceutical industry, it is still in the nascent stage. This article is our endeavor to study, in detail, the present and future opportunities of machine learning and AI in the pharmaceutical industry as a whole.
-
-
-
Artificial Intelligence in Pharmaceutical Industry: Revolutionizing Drug Development and Delivery
Artificial Intelligence (AI) has ushered in a profound revolution within the pharmaceutical sector, effectively streamlining the processes of drug development and delivery. The application of AI-driven tools and methodologies, including machine learning and natural language processing, in the realm of pharmaceutical research and development has yielded recent breakthroughs. This accelerated the drug discovery process by meticulously scrutinizing copious data and pinpointing potential drug targets, as expounded upon in this comprehensive review. Furthermore, AI has found utility in optimizing clinical trials, thereby refining trial designs and cost-effectiveness and bolstering patient safety. Notably, AI-based strategies are being harnessed to enhance drug delivery, fostering the creation of intelligent drug delivery systems engineered to target specific cells or organs. This results in heightened efficacy and a concomitant reduction in undesirable side effects. This review also delves into the potential biases residing within AI algorithms and the challenges associated with data quality when integrating AI into the pharmaceutical sphere. The findings of this study underscore the immense potential of artificial intelligence in reshaping the pharmaceutical industry, thereby enhancing the quality of life for patients worldwide.
-
-
-
Scientific Writing – ChatGPT Versus Real-time Output: Addressing Academician’s Concern
Authors: Firoz Anwar, Salman Bakr I. Hosawi, Fahad A. Al-Abbasi and Turky Omar AsarBackgroundThe advent of ChatGPT, an artificial intelligence (AI) model, has introduced new challenges in educational practices, particularly in the realm of scientific writing at higher educational institutions. The AI is trained on extensive datasets to generate scientific texts. Many professors and academicians express concerns about the inclusion of AI chatbots in project execution, interpretation, and writing within specialized subject curricula at the undergraduate and master’s levels.
MethodsTo address these concerns, we employed the ChatGPT tool by posing a specific query “Gynecomastia and the risk of non-specific lung disease, along with associated risk factors for workers in the petrochemical industry”. We conducted a comparison between responses generated by ChatGPT and real-time output from master’s students, examining document-to-document variation on different dates.
Results and DiscussionThe AI chatbot failed to identify potential risk factors, in contrast to the student response, which highlighted alteration in neutrophil levels, lung architecture, high IgE, elevated CO2 levels, etc. The two responses did not align in terms of context understanding, language nuances (words and phrases), and knowledge limitations (real-time access to information, creativity, and originality of the query). A plagiarism check using the iThenticate software reported similarity indices of 11% and 14%, respectively, in document-to-document analyses. The concerns raised by academicians are not unfounded, and the apprehension regarding students utilizing ChatGPT in the future revolves around ethical considerations, the potential for plagiarism, and the absence of laws governing the use of AI in medical or scientific writing.
ConclusionWhile AI integration in the curriculum is feasible, it should be approached with a clear acknowledgement of its limitations and benefits. Emphasizing the importance of critical thinking and original work is crucial for students engaging with AI tools, addressing concerns related to ethics, plagiarism, and potential copyright infringement in medical or scientific writings.
-
-
-
Intelligent Prediction of Photovoltaic Power Generation Considering Uncertainty Measurement
Authors: Guo-Feng Fan, Qing-Yi Ge, Si-Jie Ren, Shao-Xiang Hu and Wei-Chiang HongBackgroundAs a renewable energy, solar energy has the advantages of being non-polluting, clean, and renewable. With the variability of solar radiation, the complexity of meteorological factors, and other uncertain changes, how to measure its comprehensive uncertainty is very important.
ObjectiveThe inherent regularity of the uncertainty behavior of photovoltaic power generation is revealed by the change process of photovoltaic power generation.
MethodsUsing the empirical wavelet transform (EWT), the uncertainty measurement was studied from the perspective of social physics, and an optimized intelligent prediction model (PSOBOA-LSTM) was proposed based on the uncertainty.
ResultsThe intelligent prediction model (PSOBOA-LSTM) has a better prediction effect and higher accuracy than other models, and reveals the internal mechanism of the photovoltaic power generation system from the perspective of physics and sociology.
ConclusionUsing the PSOBOA-LSTM model can better facilitate the power dispatching department to reasonably arrange conventional power generation, coordinate operations and make maintenance arrangements based on the predicted photovoltaic power generation, and solve problems arising from the connection between grid dispatching and photovoltaic power generation forecasting.
-